Charles River Laboratories International, Inc. (CRL)
278.26
+5.26
(+1.93%)
USD |
NYSE |
Sep 11, 16:00
278.31
+0.05
(+0.02%)
Pre-Market: 20:00
Charles River Laboratories International Market Cap : 13.28B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 13.28B |
| September 10, 2026 | 13.03B |
| September 09, 2026 | 13.29B |
| September 08, 2026 | 13.40B |
| September 04, 2026 | 13.77B |
| September 03, 2026 | 14.00B |
| September 02, 2026 | 13.93B |
| September 01, 2026 | 13.48B |
| August 31, 2026 | 13.76B |
| August 28, 2026 | 13.91B |
| August 27, 2026 | 14.15B |
| August 26, 2026 | 14.08B |
| August 25, 2026 | 14.21B |
| August 24, 2026 | 14.25B |
| August 21, 2026 | 14.09B |
| August 20, 2026 | 13.91B |
| August 19, 2026 | 13.84B |
| August 18, 2026 | 13.33B |
| August 17, 2026 | 13.68B |
| August 14, 2026 | 13.37B |
| August 13, 2026 | 13.42B |
| August 12, 2026 | 13.57B |
| August 11, 2026 | 13.46B |
| August 10, 2026 | 13.22B |
| August 07, 2026 | 12.77B |
| Date | Value |
|---|---|
| August 06, 2026 | 12.67B |
| August 05, 2026 | 12.44B |
| August 04, 2026 | 11.17B |
| August 03, 2026 | 11.02B |
| July 31, 2026 | 11.20B |
| July 30, 2026 | 11.30B |
| July 29, 2026 | 11.31B |
| July 28, 2026 | 11.58B |
| July 27, 2026 | 10.80B |
| July 24, 2026 | 10.91B |
| July 23, 2026 | 11.04B |
| July 22, 2026 | 10.53B |
| July 21, 2026 | 10.57B |
| July 20, 2026 | 10.58B |
| July 17, 2026 | 10.81B |
| July 16, 2026 | 11.04B |
| July 15, 2026 | 10.99B |
| July 14, 2026 | 11.14B |
| July 13, 2026 | 11.07B |
| July 10, 2026 | 11.24B |
| July 09, 2026 | 11.25B |
| July 08, 2026 | 10.79B |
| July 07, 2026 | 11.01B |
| July 06, 2026 | 11.15B |
| July 02, 2026 | 11.11B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| IQVIA Holdings, Inc. | 43.09B |
| Medpace Holdings, Inc. | 16.36B |
| Fortrea Holdings, Inc. | 1.636B |
| Champions Oncology, Inc. | 70.82M |
| Avantor, Inc. | 10.02B |
Market Cap Related Metrics
| PS Ratio | 3.403 |
| PEG Ratio | -0.2154 |
| Price to Book Value | 4.677 |
| Price to Free Cash Flow | 36.72 |
| Price | 278.26 |
| Earnings Yield | -1.74% |
| PEGY Ratio | -0.2154 |
| Operating PE Ratio | 25.18 |
| Normalized PE Ratio | 147.89 |